148 related articles for article (PubMed ID: 1895208)
1. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
3. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
6. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
7. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
8. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
10. Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers.
Harrison NA; Skidmore SJ
J Med Virol; 1990 Oct; 32(2):128-33. PubMed ID: 2126281
[TBL] [Abstract][Full Text] [Related]
11. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study.
Shi M; Taylor JM; Currier RJ; Tang H; Hoover DR; Chmiel JS; Bryant JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):309-16. PubMed ID: 8673537
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
[TBL] [Abstract][Full Text] [Related]
13. Neopterin and alpha-interferon in patients affected by Kaposi's sarcoma from Africa.
Marfella A; Ruocco V; Capobianco A; Perna M; Santelli G; Frigione G; Kyalwazi SK; Mugerwa RD; Serwadda D; Beth-Giraldo E
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1145-50. PubMed ID: 2767104
[TBL] [Abstract][Full Text] [Related]
14. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933
[TBL] [Abstract][Full Text] [Related]
15. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
16. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
17. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
[TBL] [Abstract][Full Text] [Related]
18. [Acquired immunodeficiency syndrome (AIDS). A 2-year review].
Vogt M; Bettex JD; Lüthy R
Dtsch Med Wochenschr; 1983 Dec; 108(50):1927-33. PubMed ID: 6228417
[No Abstract] [Full Text] [Related]
19. Neopterin and beta 2-microglobulin in serum of HIV-seropositive subjects during a two-year follow-up.
Lambin P; Lefrere JJ; Doinel C; Fine JM; Salmon D; Salmon C
Clin Chem; 1988 Jun; 34(6):1367-8. PubMed ID: 3288377
[No Abstract] [Full Text] [Related]
20. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
